These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 865134)

  • 21. New approach for measurement of sympathetic nervous abnormality in conscious, spontaneously hypertensive rats.
    Tsunoda M; Takezawa K; Santa T; Ina Y; Nagashima K; Ohmori K; Kobayashi S; Imai K
    Jpn J Pharmacol; 2000 May; 83(1):39-45. PubMed ID: 10887939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse consequences of high sympathetic nervous activity in the failing human heart.
    Kaye DM; Lefkovits J; Jennings GL; Bergin P; Broughton A; Esler MD
    J Am Coll Cardiol; 1995 Nov; 26(5):1257-63. PubMed ID: 7594040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenergic activity and myocardial anatomy and function in essential hypertension.
    Muiesan G; Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1985 Dec; 3(4):S45-50. PubMed ID: 3007705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating sympathetic activity in human hypertension.
    Mancia G; Grassi G; Parati G; Daffonchio A
    J Hypertens Suppl; 1993 Dec; 11(5):S13-9. PubMed ID: 8158309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute and chronic calcium antagonist treatment elevates sympathetic activity in primary hypertension.
    Lindqvist M; Kahan T; Melcher A; Hjemdahl P
    Hypertension; 1994 Sep; 24(3):287-96. PubMed ID: 8082934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiologic and pharmacokinetic determinants of the antihypertensive response to propranolol.
    Esler M; Zweifler A; Randall O; DeQuattro V
    Clin Pharmacol Ther; 1977 Sep; 22(3):299-308. PubMed ID: 330078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic response to exercise after beta-adrenergic blockade in normal and labile hypertensive patients.
    Folle LE; Dighiero J; Sadi I; Pommerenck C; Elena R
    Cardiology; 1970; 55(2):105-13. PubMed ID: 4397324
    [No Abstract]   [Full Text] [Related]  

  • 30. Adrenergic nervous system in heart failure.
    Esler M; Kaye D; Lambert G; Esler D; Jennings G
    Am J Cardiol; 1997 Dec; 80(11A):7L-14L. PubMed ID: 9412538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma norepinephrine and age as determinants of systemic hemodynamics in men with established essential hypertension.
    Izzo JL; Smith RJ; Larrabee PS; Kallay MC
    Hypertension; 1987 Apr; 9(4):415-9. PubMed ID: 3557606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sympathetically mediated hypertension in autonomic failure.
    Shannon JR; Jordan J; Diedrich A; Pohar B; Black BK; Robertson D; Biaggioni I
    Circulation; 2000 Jun; 101(23):2710-5. PubMed ID: 10851208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The central sympathetic nervous system in hypertension.
    Mancia G; Grassi G
    Handb Clin Neurol; 2013; 117():329-35. PubMed ID: 24095136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of hypertension associated with head injury.
    Robertson CS; Clifton GL; Taylor AA; Grossman RG
    J Neurosurg; 1983 Sep; 59(3):455-60. PubMed ID: 6886759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of plasma catecholamines in humans. Correlation of resting levels with cardiac responses to beta-blocking and sympatholytic drugs.
    Thomas J; Fouad FM; Tarazi RC; Bravo EL
    Hypertension; 1983; 5(6):858-63. PubMed ID: 6140220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of autonomic and non-autonomic circulatory components in borderline hypertension in young men.
    Tanaka S; Takeshita A; Tomoike H; Nakamura M
    Jpn Heart J; 1978 Jan; 19(1):66-73. PubMed ID: 650900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular reactivity to norepinephrine and hemodynamic parameters in borderline hypertension.
    Safar ME; London GM; Weiss YA; Milliez PL
    Am Heart J; 1975 Apr; 89(4):480-6. PubMed ID: 1114980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical implications of the hemodynamic effects of beta blockade.
    Cohn JN
    Am J Cardiol; 1985 Apr; 55(10):125D-128D. PubMed ID: 2859790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents.
    Noll G; Wenzel RR; Schneider M; Oesch V; Binggeli C; Shaw S; Weidmann P; Lüscher TF
    Circulation; 1996 Mar; 93(5):866-9. PubMed ID: 8598076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of renin status to neurogenic vascular resistance in borderline hypertension.
    Esler MD; Julius S; Randall OS; Ellis CN; Kashima T
    Am J Cardiol; 1975 Oct; 36(5):708-15. PubMed ID: 1190091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.